A comparison of the effects of quetiapine and olanzapine on glucose metabolism in patients with schizophrenia

被引：0
|
作者：
Henderson, D [1 ]
Copeland, PM [1 ]
Borba, CP [1 ]
Nguyen, DD [1 ]
Evins, AE [1 ]
Zhang, H [1 ]
Hayden, D [1 ]
Freudenreich, O [1 ]
Cather, C [1 ]
Schoenfeld, D [1 ]
Goff, DC [1 ]
机构：
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA 02115 USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2005年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S494 / S495
页数：2
相关论文
共 50 条
  • [31] Resource Utilization and Costs of Schizophrenia Patients Treated with Olanzapine versus Quetiapine in a Medicaid Population
    Yu, Andrew P.
    Atanasov, Pavel
    Ben-Hamadi, Rym
    Birnbaum, Howard
    Stensland, Michael D.
    Philips, Glenn
    [J]. VALUE IN HEALTH, 2009, 12 (05) : 708 - 715
  • [32] Comparing the treatment patterns of patients with schizophrenia treated with olanzapine and quetiapine in the Pennsylvania Medicaid population
    Yu, Andrew P.
    Ben-Hamadi, Rym
    Birnbaum, Howard G.
    Atanasov, Pavel
    Stensland, Michael D.
    Philips, Glenn
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (03) : 755 - 764
  • [33] The metabolic and clinical effects of olanzapine and quetiapine: Preliminary findings from a randomized single-blind trial in patients with schizophrenia
    Ozguven, HD
    Oner, O
    Baskak, B
    Oner, P
    Atbasoglu, EC
    [J]. SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 190 - 191
  • [34] Antipsychotic monotherapy with olanzapine, risperidone, and quetiapine in the treatment of schizophrenia.
    Faries, D
    Zhu, BJ
    Jiang, Q
    Ascher-Svanum, H
    [J]. PHARMACOTHERAPY, 2003, 23 (10): : 1359 - 1360
  • [35] Comparison of risperidone, olanzapine and quetiapine in relation to body weight, serum blood glucose and prolactin levels
    Chaudhry, H. R.
    Niaz, S.
    Arshad, N.
    Peracha, F.
    Ayub, A.
    Mufti, K. A.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S241 - S241
  • [36] Neurocognition and its influencing factors in the treatment of schizophrenia-effects of aripiprazole, olanzapine, quetiapine and risperidone
    Riedel, M.
    Schennach-Wolff, R.
    Musil, R.
    Dehning, S.
    Cerovecki, A.
    Opgen-Rhein, M.
    Matz, J.
    Seemueller, F.
    Obermeier, M.
    Engel, R. R.
    Mueller, N.
    Moeller, H.-J.
    Spellmann, I.
    [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2010, 25 (02) : 116 - 125
  • [37] Effects of risperidone on glucose metabolism in Chinese patients with schizophrenia: A prospective study
    Chen, Qi
    Cai, Zhuo-ji
    Mao, Pei-xian
    Zhai, Yi-Ming
    Mitchell, Philip B.
    Tang, Yi-lang
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2008, 43 (02) : 124 - 128
  • [38] Quetiapine ('Seroquel') and olanzapine for acute treatment of patients with schizophrenia: An open-label, comparative study
    Reznik, I
    Slavkin, L
    Shabash, E
    Shaked, G
    Kertzman, S
    Spivak, B
    Weizman, A
    Kotler, M
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S244 - S244
  • [39] Weight gain in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol:: results of the EIRE study
    Bobes, J
    Rejas, J
    Garcia-Garcia, M
    Rico-Villademoros, F
    García-Portilla, MP
    Fernández, I
    Hernández, G
    [J]. SCHIZOPHRENIA RESEARCH, 2003, 62 (1-2) : 77 - 88
  • [40] Diabetes risk associated with use of olanzapine, quetiapine, and risperidone in Veterans Health Administration patients with schizophrenia
    Lambert, Bruce L.
    Cunningham, Francesca E.
    Miller, Donald R.
    Dalack, Gregory W.
    Hur, Kwan
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2006, 164 (07) : 672 - 681
12345